Back to
DRIEHAUS CAPITAL MANAGEMENT LLC
CRNX25 quarters
Position history for
DRIEHAUS CAPITAL MANAGEMENT LLC's holdings in <![CDATA[CRINETICS PHARMACEUTICALS INC]]>
Yes. Driehaus Capital Management holds 6,463,551 shares of CRNX (<![cdata[crinetics Pharmaceuticals Inc]]>), worth $241.9M, as of its Q2 2026 13F filing. It increased the position by 67,629 shares (+1.1%) from Q1 2026. Driehaus Capital Management has held CRNX since Q2 2020, across 25 quarterly 13F filings. CRNX is 1.4% of Driehaus Capital Management's reported 13F portfolio.
Current Value
$241.9M
Current Shares
6.5M
Total Value Change
+$226.3M
Total Shares Change
+5.6M
Quarter-by-Quarter History
Other major holders of CRNX: FMR LLC